A detailed history of Black Rock Inc. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,552,560 shares of ARDX stock, worth $84.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,552,560
Previous 17,096,038 2.67%
Holding current value
$84.6 Million
Previous $125 Million 4.22%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.89 - $9.31 $2.69 Million - $4.25 Million
456,522 Added 2.67%
17,552,560 $130 Million
Q1 2024

May 10, 2024

BUY
$6.05 - $9.74 $1.94 Million - $3.12 Million
319,983 Added 1.91%
17,096,038 $125 Million
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $7.72 Million - $15.6 Million
2,346,367 Added 16.26%
16,776,055 $104 Million
Q3 2023

Nov 13, 2023

BUY
$3.3 - $4.83 $1.32 Million - $1.93 Million
399,296 Added 2.85%
14,429,688 $58.9 Million
Q2 2023

Aug 11, 2023

BUY
$3.23 - $4.95 $33.4 Million - $51.1 Million
10,325,699 Added 278.72%
14,030,392 $47.6 Million
Q1 2023

May 12, 2023

BUY
$2.68 - $4.79 $2.65 Million - $4.74 Million
989,784 Added 36.46%
3,704,693 $17.7 Million
Q4 2022

Feb 13, 2023

BUY
$1.22 - $2.85 $1.45 Million - $3.39 Million
1,188,708 Added 77.89%
2,714,909 $7.74 Million
Q3 2022

Nov 14, 2022

BUY
$0.59 - $1.44 $136,010 - $331,958
230,527 Added 17.79%
1,526,201 $1.82 Million
Q2 2022

Aug 12, 2022

SELL
$0.51 - $1.17 $2.25 Million - $5.15 Million
-4,404,902 Reduced 77.27%
1,295,674 $764,000
Q1 2022

May 12, 2022

BUY
$0.65 - $1.18 $46,534 - $84,478
71,592 Added 1.27%
5,700,576 $6.1 Million
Q4 2021

Feb 10, 2022

SELL
$0.86 - $1.7 $711,149 - $1.41 Million
-826,918 Reduced 12.81%
5,628,984 $6.19 Million
Q3 2021

Nov 09, 2021

BUY
$1.27 - $8.17 $300,997 - $1.94 Million
237,006 Added 3.81%
6,455,902 $8.52 Million
Q2 2021

Aug 11, 2021

BUY
$6.55 - $8.98 $40.7 Million - $55.8 Million
6,218,896 New
6,218,896 $47.1 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $745M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.